ANTICORPS DIRIGÉ CONTRE LA PODOCALYXINE ET LES GROUPES TRA ASSOCIÉS, MÉTHODES DE PRÉPARATION ET UTILISATIONS EN TANT QU'AGENT THÉRAPEUTIQUE CONTRE LE CANCER
The invention relates to an antibody or an antigen-binding fragment thereof, including a heavy chain and a light chain, with heavy chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 1 to 3, respectively, and light chain complementarity determining regions 1 to 3 having the amino acid sequences of SEQ ID NOS. 4 to 6, respectively. In addition, the invention relates to an anti-cancer therapeutic agent including the antibody or the antigen-binding fragment thereof.